Figure 1.
![Comparison of overall survival and posttransplant survival of patients with primary myelofibrosis (PMF) stratified by race (Black African American vs non-African-American∗). ∗95% Caucasian. (A) Overall survival of 1354 patients with PMF stratified based on race (Black AA vs non-AA [95% Caucasian]). (B) Posttransplant survival of 76 patients with PMF stratified based on race (Black AA vs non-AA [95% Caucasian]).](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/7/12/10.1182_bloodadvances.2022009611/2/blooda_adv-2022-009611-gr1.jpeg?Expires=1719001956&Signature=41K9y5ksl-FYzLF6V4t-jRNGVc9yjIpjjJX3B23eZ~7719VJUS4Q1QH9bIB1dLgDIwU-dqupAL5jaTPGTIHz9MC9zCZeglIfaS2Ed50TC8Fq760xpcuglNas0Aaya9kba48cv528k3rOUoES8W7TrL~HFwL9IAjcHu~Ujv3fG3p6-EPIPJX0Zy-n~qXCJsucV0K7wD-Uw0MfCh-HdMub12ZSeN6BHJosZzZBVS-2WH7NLEa66Zo2eeeSgK8FzzKuosdcg0PWlHnU5QrTmGFSJjhILm8zG62q~Tha0qbi4KuYfwzHBB~t7Iid6dQKKnw21Nd1NL62YmDLdwxGBvhV2A__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Comparison of overall survival and posttransplant survival of patients with primary myelofibrosis (PMF) stratified by race (Black African American vs non-African-American∗). ∗95% Caucasian. (A) Overall survival of 1354 patients with PMF stratified based on race (Black AA vs non-AA [95% Caucasian]). (B) Posttransplant survival of 76 patients with PMF stratified based on race (Black AA vs non-AA [95% Caucasian]).
